Multiple system atrophy

doi:10.1017/CBO9780511544873.044

43 - Multiple system atrophy

from Part VII - Parkinson's and related movement disorders

Published online by Cambridge University Press: 04 August 2010

Anthony E. Lang and

Carlo Colosimo and

M. Flint Beal: Affiliation:
Cornell University, New York
Anthony E. Lang: Affiliation:
University of Toronto
Albert C. Ludolph: Affiliation:
Universität Ulm, Germany
Felix Geser: Affiliation:
Clinical Department of Neurology, Innsbruck Medical University, Austria
Carlo Colosimo: Affiliation:
Department of Neurology, University “La Sapienza” Rome, Italy
Gregor. K. Wenning: Affiliation:
Clinical Department of Neurology, Innsbruck Medical University, Austria

Book contents

Get access

Summary

Historical review

The term multiple system atrophy (MSA) was introduced by Graham and Oppenheimer in 1969 to denote a neurodegenerative disease characterized clinically by various combinations of autonomic, parkinsonian, cerebellar or pyramidal symptoms and signs and pathologically by cell loss and gliosis in some or all of the following structures: putamen, caudate nucleus, globus pallidus, substantia nigra, locus ceruleus, inferior olives, pontine nuclei, cerebellar Purkinje cells, intermediolateral cell columns and Onuf's nucleus of the spinal cord.

Previously, cases of MSA were reported under the rubrics of olivopontocerebellar atrophy (OPCA), idiopathic orthostatic hypotension (IOH) or progressive autonomic failure (PAF), Shy–Drager syndrome (SDS) and striatonigral degeneration (SND). Although Dejerine and Thomas were the first to introduce the term OPCA in 1900 reporting two sporadic cases of late-onset ataxia, the case of Stauffenberg in 1918, diagnosed in life as OPCA, was the first to associate cerebellar, parkinsonian and autonomic features with identified pathological lesions not only of olives, pons and cerebellum, but also of basal ganglia pigmentation and atrophy of putamen, with additional cell loss in caudate and globus pallidus (Quinn, 1994).

The term SND was introduced in 1960 by van der Eecken, Adams and van Bogaert (van der Eecken et al., 1960; Adams et al., 1961, 1964) who noted pronounced shrinkage and brownish discoloration of the putamen and pallidum as well as depigmentation of the substantia nigra in three patients with progressive and severe parkinsonism associated with cerebellar, pyramidal and autonomic features.

Type: Chapter
Information: Neurodegenerative Diseases
Neurobiology, Pathogenesis and Therapeutics
, pp. 623 - 662

DOI: https://doi.org/10.1017/CBO9780511544873.044 [Opens in a new window]

Publisher: Cambridge University Press

Print publication year: 2005

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Book purchase

Temporarily unavailable

References

Abbruzzese, G., Marchese, R. & Trompetto, C. (1997). Sensory and motor evoked potentials in multiple system atrophy: comparative study with Parkinson's disease. Mov. Disord., 12(3), 315–21CrossRef Google Scholar PubMed

Abele, M., Schulz, J. B., Burk, K., Topka, H., Dichgans, J. & Klockgether, T. (2000a). Evoked potentials in multiple system atrophy (MSA). Acta Neurol. Scand., 101(2), 111–15CrossRef Google Scholar

Abele, M., Schulz, J. B., Burk, K., Topka, H., Dichgans, J. & Klockgether, T. (2000b). Nerve conduction studies in multiple system atrophy. Eur. Neurol., 43(4), 221–3CrossRef Google Scholar

Abele, M., Burk, K., Schols, L.et al. (2002). The aetiology of sporadic adult-onset ataxia. Brain, 125(5), 961–8CrossRef Google Scholar PubMed

Abeliovich, A., Schmitz, Y., Farinas, I.et al. (2000). Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron, 25(1), 239–52CrossRef Google Scholar PubMed

Adams, R. D., Bogaert, L. & Eecken, H. (1961). Dégénérescences nigro-striées et cérébello-nigro-striees. Psychiat. Neurol. 142, 219–59CrossRef Google Scholar

Adams, R. D., Bogaert, L. & Eecken, H. (1964). Striato-nigral degeneration. J. Neuropathol. Expl. Neurol., 23, 584–608Google Scholar PubMed

Alam, M., Smith, G., Bleasdal-Barr, K., Pavitt, D. V. & Mathias, C. J. (1995). Effects of the peptide release inhibitor, octreotide, on daytime hypotension and on nocturnal hypertension in primary autonomic failure. J. Hypertens., 13(12/2), 1664–9Google Scholar PubMed

Albanese, A., Colosimo, C., Bentivoglio, A. R.et al. (1995). Multiple system atrophy presenting as parkinsonism: clinical features and diagnostic criteria. J. Neurol. Neurosurg. Psychiatr., 59(2), 144–51CrossRef Google Scholar PubMed

Allan, S. M. & Rothwell, N. J. (2001). Cytokines and acute neurodegeneration. Nat. Rev. Neurosci., 2(10), 734–44CrossRef Google Scholar PubMed

Aloe, L. & Fiore, M. (1997). TNF-alpha expressed in the brain of transgenic mice lowers central tyroxine hydroxylase immunoreactivity and alters grooming behaviour. Neurosci. Lett., 238(1–2), 65–8CrossRef Google Scholar

Ansorge, O., Lees, A. J., Brooks, D. J. & Daniel, S. E. (1997a). Multiple system atrophy presenting as progressive supranuclear palsy and vice-versa: two unusual cases. Mov. Disord., 12(suppl.1), 96Google Scholar

Ansorge, O., Lees, A. J. & Daniel, S. E. (1997b). Pathological overlap of Alzheimer's disease, Parkinson's disease and multiple system atrophy. Neuropathol. Appl. Neurobiol., 23, 179Google Scholar

Antonini, A., Kazumata, K., Feigin, A.et al. (1998). Differential diagnosis of parkinsonism with [18F]fluorodeoxyglucose and PET. Mov. Disord., 13(2), 268–74CrossRef Google Scholar

Arima, K., Nakamura, M., Sunohara, N.et al. (1997). Ultrastructural characterization of the tau-immunoreactive tubules in the oligodendroglial perikarya and their inner loop processes in progressive supranuclear palsy. Acta Neuropathol. (Berl.), 93(6), 558–66CrossRef Google Scholar PubMed

Arima, K., Ueda, K., Sunohara, N.et al. (1998). NACP/alpha-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy. Acta Neuropathol. (Berl.), 96(5), 439–44CrossRef Google Scholar PubMed

Baker, M., Litvan, I., Houlden, H.et al. (1999). Association of an extended halotype in the tau gene with progressive supranuclear palsy. Hum. Mol. Genet., 8(4), 711–15CrossRef Google Scholar

Bandmann, O., Wenning, G. K., Quinn, N. P. & Harding, A. E. (1995). Arg296 to Cys296 polymorphism in exon 6 of cytochrome P-450–2D6 (CYP2D6) is not associated with multiple system atrophy. J. Neurol. Neurosurg. Psychiatr., 59(5), 557CrossRef Google Scholar

Bandmann, O., Sweeney, M. G., Daniel, S. E.et al. (1997). Multiple-system atrophy is genetically distinct from identified inherited causes of spinocerebellar degeneration. Neurology, 49(6), 1598–604CrossRef Google Scholar PubMed

Bannister, R. & Oppenheimer, D. R. (1972). Degenerative diseases of the nervous system associated with autonomic failure. Brain, 95(3), 457–74Google Scholar PubMed

Bannister, R. & Mathias, C. J. (1999a). Clinical features and evaluation of the primary chronic autonomic failure syndromes. In Autonomic Failure. A Textbook of Clinical Disorders of the Autonomic Nervous System., ed. C. J. Mathias & R. Bannister. Oxford: Oxford University Press, pp. 307–16

Bannister, R. & Mathias, C. J. (1999b). Investigation of autonomic disorders. In Autonomic Failure. A Textbook of Clinical Disorders of the Autonomic Nervous System, ed. C. J. Mathias & R. Bannister. Oxford: Oxford University Press, pp. 169–95

Barres, B. A., Hart, I. K., Coles, H. S.et al. (1992). Cell death and control of cell survival in the oligodendrocyte lineage. Cell, 70(1), 31–46CrossRef Google Scholar PubMed

Baser, S. M., Meer, J., Polinsky, R. J. & Hallett, M. (1991). Sudomotor function in autonomic failure. Neurology, 41(10), 1564–6CrossRef Google Scholar PubMed

Beck, R. O., Betts, C. D. & Fowler, C. J. (1994). Genitourinary dysfunction in multiple system atrophy: clinical features and treatment in 62 cases. J. Urol., 151(5), 1336–41CrossRef Google Scholar PubMed

Benarroch, E. E., Smithson, I. L., Low, P. A. & Parisi, J. E. (1998). Depletion of catecholaminergic neurons of the rostral ventrolateral medulla in multiple systems atrophy with autonomic failure. Ann. Neurol., 43(2), 156–63CrossRef Google Scholar PubMed

Ben-Shlomo, Y., Wenning, G. K., Tison, F. & Quinn, N. P. (1997). Survival of patients with pathologically proven multiple system atrophy: a meta-analysis. Neurology, 48, 384–93CrossRef Google Scholar PubMed

Berciano, J., Combarros, O., Polo, J. M., Pascual, J. & Oterino, A. (1998). Who first described striatonigral degeneration?Neurology, 50(suppl 4), 120Google Scholar

Berciano, J., Valldeoriola, F., Ferrer, I.et al. (2002). Presynaptic parkinsonism in multiple system atrophy mimicking Parkinson's disease: a clinicopathological case study. Mov. Disord., 17(4), 812–16CrossRef Google Scholar PubMed

Bermingham-McDonogh, O., McCabe, K. L. & Reh, T. A. (1996). Effects of GGF/neuregulins on neuronal survival and neurite outgrowth correlate with erbB2/neu expression in developing rat retina. Development, 122(5), 1427–38Google Scholar PubMed

Bösch, S. M., Schocke, M., Seppi, K., Hollosi, P., Poewe, W. & Wenning, G. K. (2002a). Abnormal striatal dopaminergic function in SCA2 revealed by beta-CIT and IBZM SPECT. Mov. Disord., 17(Suppl 5), 311Google Scholar

Bösch, S. M., Wenning, G. K., Ransmayr, G. & Poewe, W. (2002b). Dystonia in multiple system atrophy. J. Neurol. Neurosurg. Psychiatr., 72(3), 300–3CrossRef Google Scholar

Boka, G., Anglade, P., Wallach, D., Javoy-Agid, F., Agid, Y. & Hirsch, E. C. (1994). Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease. Neurosci. Lett., 172(1–2), 151–4CrossRef Google Scholar PubMed

Botez, M. I. & Young, S. N. (2001). Biogenic amine metabolites and thiamine in cerebrospinal fluid in heredodegenerative ataxias. Can. J. Neurol. Sci., 28(2), 134–40CrossRef Google Scholar

Bower, J. H., Maraganore, D. M., McDonnell, S. K. & Rocca, W. A. (1997). Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990. Neurology, 49, 1284–8CrossRef Google Scholar PubMed

Braak, H. & Braak, E. (1989). Cortical and subcortical argyrophilic grains characterize a disease associated with adult onset dementia. Neuropathol. Appl. Neurobiol., 15(1), 13–26CrossRef Google Scholar PubMed

Braune, S., Auer, A., Schulte-Mönting, J., Schwerbrock, S. & Lücking, C. H. (1996a). Cardiovascular parameters: sensitivity to detect autonomic dysfunction and influence of age and sex in normal subjects. Clin. Auton. Res., 6, 3–15CrossRef Google Scholar

Braune, S., Schulte-Monting, J., Schwerbrock, S. & Lucking, C. H. (1996b). Retest variation of cardiovascular parameters in autonomic testing. J. Auton. Nerv. Syst., 60(3), 103–7CrossRef Google Scholar

Braune, S., Elam, M., Baron, R. & Low, P. A. (1999a). Assessment of blood pressure regulation. The International Federation of Clinical Neurophysiology. Electroencephalogr. Clin. Neurophysiol., Supp., 52, 287–91Google Scholar

Braune, S., Reinhardt, M., Schnitzer, R., Riedel, A. & Lücking, C. H. (1999b). Cardiac uptake of (123I)MIBG separates Parkinson's disease from multiple system atrophy. Neurology, 53(5), 1020–5CrossRef Google Scholar

Brenneis, C., Seppi, K., Schocke, M. F.et al. (2003). Voxel-based morphometry detects cortical atrophy in the parkinson variant of multiple system atrophy. Mov. Disord., 18(10), 1132–8CrossRef Google Scholar PubMed

Brooks, D. J., Luthert, P., Gadian, D. & Marsden, C. D. (1989). Does signal-attenuation on high-field T2-weighted MRI of the brain reflect regional cerebral iron deposition? Observations on the relationship between regional cerebral water proton T2-values and iron levels. J. Neurol. Neurosurg. Psychiatr., 52, 108–11CrossRef Google Scholar

Brooks, D. J., Ibanez, V., Sawle, G. V.et al. (1990a). Differing patterns of striatal 18-F-Dopa uptake in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy. Ann. Neurol., 28, 547–55CrossRef Google Scholar

Brooks, D. J., Salmon, E. P., Mathias, C. J.et al. (1990b). The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure, and Parkinson's disease, studied with PET. Brain, 113, 1539–52CrossRef Google Scholar

Brooks, D. J., Ibanez, V., Sawle, G. V.et al. (1992). Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography. Ann. Neurol., 31(2), 184–92CrossRef Google Scholar PubMed

Brown, R. G., Pillon, B., Uttner, I., Payan, C. & Lacomblez, L. (2002). Members of the Neuropsychology Working Group and NNIPPS Consortium. Cognitive function in patients with Progressive Supranuclear Palsy (PSP) and Multiple System Atrophy (MSA). Mov. Disord., 17(Suppl 5), 221Google Scholar

Brücke, T., Wenger, S. & Asenbaum, S. (1993). Dopamine D2 receptor imaging and measurement with SPECT. Adv. Neurol., 60, 494–500Google Scholar PubMed

Brücke, T., Asenbaum, S., Pirker, W.et al. (1997). Measurement of the dopaminergic degeneration in Parkinson's disease with [123I] beta-CIT and SPECT. Correlation with clinical findings and comparison with multiple system atrophy and progressive supranuclear palsy. J. Neural Transm. Suppl., 50, 9–24CrossRef Google Scholar PubMed

Brücke, T., Djamshidian, S., Bencsits, G., Pirker, W., Asenbaum, S. & Podreka, I. (2000). SPECT and PET imaging of the dopaminergic system in Parkinson's disease. J. Neurol., 247(4), IV/2–7CrossRef Google Scholar PubMed

Burden, S. & Yarden, Y. (1997). Neuregulins and their receptors: a versatile signaling module in organogenesis and oncogenesis. Neuron, 18(6), 847–55CrossRef Google Scholar PubMed

Burn, D. J. & Jaros, E. (2001). Multiple system atrophy: cellular and molecular pathology. Mol. Pathol., 54(6), 419–26Google Scholar PubMed

Burn, D. J., Sawle, G. V. & Brooks, D. J. (1994). Differential diagnosis of Parkinson's disease, multiple system atrophy, and Steele–Richardson–Olszewski syndrome: discriminant analysis of striatal 18F-dopa PET data. J. Neurol. Neurosurg. Psychiatr., 57(3), 278–84CrossRef Google Scholar PubMed

Burn, D. J., Rinne, J. O., Quinn, N. P., Lees, A. J., Marsden, C. D. & Brooks, D. J. (1995). Striatal opioid receptor binding in Parkinson's disease, striatonigral degeneration and Steele–Richardson–Olszewski syndrome. A [11C]diprenorphine PET study. Brain, 118(4), 951–8CrossRef Google Scholar PubMed

Buttery, P. C. & ffrench-Constant, C. (1999). Laminin-2/integrin interactions enhance myelin membrane formation by oligodendrocytes. Mol. Cell. Neurosci., 14(3), 199–212CrossRef Google Scholar PubMed

Cairns, N. J., Atkinson, P. F., Hanger, D. P., Anderton, B. H., Daniel, S. E. & Lantos, P. L. (1997a). Tau protein in the glial cytoplasmatic inclusions of multiple system atrophy can be distinguished from abnormal tau in Alzheimer's disease. Neurosci. Lett., 230(1), 49–52CrossRef Google Scholar

Cairns, N. J., Atkinson, P. F., Kovacs, T., Lees, A. J., Daniel, S. E. & Lantos, P. L.Apolipoprotein E ε4 allele frequency in patients with multiple system atrophy. Neurosci. Lett., 221(2–3), 161–4CrossRef

Canoll, P. D., Musacchio, J. M., Hardy, R., Reynolds, R., Marchionni, M. A. & Salzer, J. L. (1996). GGF/neuregulin is a neuronal signal that promotes the proliferation and survival and inhibits the differentiation of oligodendrocyte progenitors. Neuron, 17(2), 229–43CrossRef Google Scholar PubMed

Canoll, P. D., Kraemer, R., Teng, K. K., Marchionni, M. A. & Salzer, J. L. (1999). GGF/neuregulin induces a phenotypic reversion of oligodendrocytes. Mol. Cell. Neurosci., 13(2), 79–94CrossRef Google Scholar PubMed

Caplan, L. R. (1984). Clinical features of sporadic (Dejerine-Thomas) olivopontocerebellar atrophy. Adv. Neurol., 41, 217–24Google Scholar PubMed

Chandiramani, V. A., Palace, J. & Fowler, C. J. (1997). How to recognize patients with parkinsonism who should not have urological surgery. Br. J. Urol., 80(1), 100–4CrossRef Google Scholar

Chin, S. S. & Goldman, J. E. (1996). Glial inclusions in CNS degenerative diseases. J. Neuropathol. Exp. Neurol., 55(5), 499–508CrossRef Google Scholar PubMed

Chio, A., Magnani, C. & Schiffer, D. (1998). Prevalence of Parkinson's disease in northwestern Italy: comparison of tracer methodology and clinical ascertainment of cases. Mov. Disord., 13(3), 400–5CrossRef Google Scholar PubMed

Churchyard, A., Donnan, G. A., Hughes, A.et al. (1993). Dopa resistance in multiple-system atrophy: loss of postsynaptic D2 receptors. Ann. Neurol., 34(2), 219–26CrossRef Google Scholar PubMed

Clarke, C. E. & Lowry, M. (2000). Basal ganglia metabolite concentrations in idiopathic Parkinson's disease and multiple system atrophy measured by proton magnetic resonance spectroscopy. Eur. J. Neurol., 7(6), 661–5CrossRef Google Scholar PubMed

Clarke, C. E., Ray, P. S. & Speller, J. M. (1999). Failure of the clonidine growth hormone stimulation test to differentiate multiple system atrophy from early or advanced idiopathic Parkinson's disease. The Lancet, 353, 1329–30CrossRef Google Scholar PubMed

Clayton, D. F. & George, J. M. (1999). Synucleins in synaptic plasticity and neurodegenerative disorders. J. Neurosci. Res., 58(1), 120–93.0.CO;2-E>CrossRef Google Scholar PubMed

Cohen, J., Low, P., Fealey, R., Sheps, S. & Jiang, N. S. (1987). Somatic and autonomic function in progressive autonomic failure and multiple system atrophy. Ann. Neurol., 22, 692–9CrossRef Google Scholar PubMed

Colosimo, C. (1998). Pisa syndrome in a patient with multiple system atrophy. Mov. Disord., 13(3), 607–9CrossRef Google Scholar

Colosimo, C. & Pezzella, F. R. (2002). The symptomatic treatment of multiple system atrophy. Eur. J. Neurol., 9(3), 195–9CrossRef Google Scholar PubMed

Colosimo, C., Merello, M. & Pontieri, F. E. (1996). Amantadine in parkinsonian patients unresponsive to levodopa: a pilot study. J. Neurol., 243, 422–5CrossRef Google Scholar PubMed

Colosimo, C., Albanese, A., Hughes, A. J., Bruin, V. M. & Lees, A. J. (1995). Some specific clinical features differentiate multiple system atrophy (striatonigral variety) from Parkinson's disease. Arch. Neurol., 52(3), 294–8CrossRef Google Scholar PubMed

Colosimo, C., Inghilleri, M. & Chaudhuri, K. R. (2000). Parkinson's disease misdiagnosed as multiple system atrophy by sphincter electromyography. J. Neurol., 247, 559–61CrossRef Google Scholar

Colosimo, C., Geser, F. and Wenning, G. K. (2004). Clinical spectrum and pathological features of multiple system atrophy. In: Animal Models of Movement Disorders, ed. M. LeDoux, pp. 541–70. Amsterdam: Elsevier

Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. (1996). J. Neurol. Sci., 144(1–2), 218–19

Cortes, R., Camps, M., Gueye, B., Probst, A. & Palacios, J. M. (1989). Dopamine receptors in human brain: autoradiographic distribution of D1 and D2 sites in Parkinson syndrome of different etiology. Brain Res., 483(1), 30–8CrossRef Google Scholar PubMed

Daniel, S. E. (1999). The neuropathology and neurochemistry of multiple system atrophy. In Autonomic Failure. A Textbook of Clinical Disorders of the Autonomic Nervous System, ed. C. J. Mathias & R. Bannister. Oxford: Oxford University Press, pp. 321–8

Davie, C. A., Wenning, G. K., Barker, G. J.et al. (1995). Differentiation of multiple system atrophy from idiopathic Parkinson's disease using proton magnetic resonance spectroscopy. Ann. Neurol., 37, 204–10CrossRef Google Scholar PubMed

Dejerine, J. & Thomas, A. A. (1900). L'atrophie olivo-ponto-cérébelleuse. Nouv. Iconogr. Salpêtrièr., 13, 330–70Google Scholar

Delalande, I., Hache, J. C., Forzy, G., Bughin, M., Benjadjali, J. & Destee, A. (1998). Do visual-evoked potentials and spatiotemporal contrast sensitivity help to distinguish idiopathic Parkinson's disease and multiple system atrophy?Mov. Disord., 13(3), 446–52CrossRef Google Scholar PubMed

Volder, A. G., Francart, J., Laterre, C.et al. (1989). Decreased glucose utilization in the striatum and frontal lobe in probable striatonigral degeneration. Ann. Neurol., 26, 239–47CrossRef Google Scholar PubMed

Dexter, D. T., Carayon, A., Javoy-Agid, F.et al. (1991). Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain, 114(4), 1953–75CrossRef Google Scholar PubMed

Dickson, D. W., Liu, W., Hardy, J.et al. (1999a). Widespread alterations of alpha-synuclein in multiple system atrophy. Am. J. Pathol., 155(4), 1241–51CrossRef Google Scholar

Dickson, D. W., Lin, W., Liu, W. K. & Yen, S. H. (1999b). Multiple system atrophy: a sporadic synucleinopathy. Brain Pathol., 9(4), 721–32CrossRef Google Scholar

Drayer, B. P., Olanow, W., Burger, P., Johnson, G. A., Herfkens, R. & Ricderer, S. (1986). Parkinson Plus Syndrome: diagnosis using high field MR imaging of brain iron. Radiology, 159, 493–8CrossRef Google Scholar

Duda, J. E., Shah, U., Arnold, S. E., Lee, V. M. & Trojanowski, J. Q. (1999). The expression of alpha-, beta-, and gamma-synucleins in olfactory mucosa from patients with and without neurodegenerative diseases. Exp. Neurol., 160(2), 515–22CrossRef Google Scholar PubMed

Eardley, I., Quinn, N. P., Fowler, C. J.et al. (1989). The value of urethral sphincter electromyography in the differential diagnosis of parkinsonism. Br. J. Urol., 64, 360–2CrossRef Google Scholar PubMed

Eichhorn, T. E. & Oertel, W. H. (2001). Macrogol 3350/electrolyte improves constipation in Parkinson's disease and multiple system atrophy. Mov. Disord., 16(6), 1176–7CrossRef Google Scholar PubMed

Eidelberg, D., Takikawa, S., Moeller, J. R.et al. (1993). Striatal hypometabolism distinguishes striatonigral degeneration from Parkinson's disease. Ann. Neurol., 33, 518–27CrossRef Google Scholar PubMed

El-Agnaf, O. M., Curran, M. D., Wallace, A.et al. (1998). Mutation screening in exons 3 and 4 of alpha-synuclein in sporadic Parkinson's and sporadic and familial dementia with Lewy bodies cases. Neuroreport, 9(17), 3925–7CrossRef Google Scholar PubMed

Ellis, C., Lemmens, G., Williams, S. C. R., Simmons, A., Leigh, P. N. & Chaudhuri, K. R. (1996). Striatal changes in striatonigral degeneration and Parkinson's disease: a proton magnetic resonance spectroscopy study. Mov. Disord., 11, 104Google Scholar

Ellis, C. E., Schwartzberg, P. L., Grider, T. L., Fink, D. W. & Nussbaum, R. L. (2001). Alpha-synuclein is phosphorylated by members of the Src family of protein-tyrosine kinases. J. Biol. Chem., 276(6), 3879–84CrossRef Google Scholar PubMed

Engelender, S., Kaminsky, Z., Guo, X.et al. (1999). Synphilin-I associates with alpha-synuclein and promotes the formation of cytosolic inclusions. Nat. Genet., 22(1), 110–14CrossRef Google Scholar PubMed

Fearnley, J. M. & Lees, A. J. (1990). Striatonigral degeneration. A clinico-pathological study. Brain, 113(6), 1823–42CrossRef Google Scholar

Fearnley, J. M. & Lees, A. J. (1991). Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain, 114(5), 2283–301CrossRef Google Scholar PubMed

Federico, F., Simone, I. L., Lucivero, V.et al. (1999). Usefulness of proton magnetic resonance spectroscopy in differentiating parkinsonian syndromes. Ital. J. Neurol. Sci., 20(4), 223–9CrossRef Google Scholar PubMed

Fernagut, P., Diguet, E., Stefanova, N.et al. (2002). Subacute systemic 3-nitropropionic acid intoxication induces a distinct motor disorder in adult C57Bl/6 mice: behavioural and histopathological characterisation. Neuroscience, 114(4), 1005–17CrossRef Google Scholar PubMed

Fleischhacker, H. (1924). Afamiliäre chronisch progressive Erkrankung des mittleren Lebensalters vom Pseudosklerosetyp. Z. Gesamte Neurol. Psychiatri., 91, 1–22CrossRef Google Scholar

Flugel, K. A., Mosler, T. A. & Wild, R. H. (1984). Bulbar paralytic symptoms including acute vocal cord paralysis in Shy-Drager syndrome. Nervenarzt, 55(6), 293–8Google Scholar PubMed

Frost, E. E., Buttery, P. C., Milner, R. & ffrench-Constant, C. (1999). Integrins mediate a neuronal survival signal for oligodendrocytes. Curr. Biol., 9(21), 1251–4CrossRef Google Scholar PubMed

Fujita, T., Doi, M., Ogata, T., Kanazawa, I. & Mizusawa, H. (1993). Cerebral cortical pathology of sporadic olivopontocerebellar atrophy. J. Neurol. Sci., 116(1), 41–6CrossRef Google Scholar PubMed

Futamura, N., Matsumura, R., Fujimoto, Y., Horikawa, H., Suzumura, A. & Takayanagi, T. (1998). CAG repeat expansions in patients with sporadic cerebellar ataxia. Acta Neurol. Scand., 98(1), 55–9CrossRef Google Scholar PubMed

Gahring, L. C., Rogers, S. W. & Twyman, R. E. (1997). Autoantibodies to glutamate receptor subunit GluR2 in nonfamilial olivopontocerebellar degeneration. Neurology, 48(2), 494–500CrossRef Google Scholar PubMed

Gai, W. P., Power, J. H., Blumbergs, P. C. & Blessing, W. W. (1998). Multiple-system atrophy: a new alpha-synuclein disease?Lancet, 352(9127), 547–8CrossRef Google Scholar PubMed

Gai, W. P., Pountney, D. L., Power, J. H.et al. (2003). α-Synuclein fibrils constitute the central core of oligodendroglial inclusion filaments in multiple system atrophy. Exp. Neurol., 181(1), 68–78CrossRef Google Scholar PubMed

Garratt, H., Wenning, G. K., Barnes, C., Howard, R. & Quinn, N. P. (1994). Speech dysfunction and levodopa response in multiple system atrophy. N. Trends Clin. Neuropharmacol., 206–7Google Scholar

Gash, D. M., Zhang, Z. & Gerhardt, G. (1998). Neuroprotective and neurorestorative properties of GDNF. Ann. Neurol., 44(3 Suppl 1), 121–5CrossRef Google Scholar PubMed

Gerhard, A., Banati, R., Cagnin, A.et al. (2000). In vivo imaging of activated microglia with [11C]PK11195 positron emission tomography in patients with multiple system atrophy. Mov. Disord., 15(Suppl. 3), 215–16Google Scholar

Ghaemi, M., Hilker, R., Rudolf, J., Sobesky, J. & Heiss, W. D. (2002). Differentiating multiple system atrophy from Parkinson's disease: contribution of striatal and midbrain MRI volumetry and multi-tracer PET imaging. J. Neurol. Neurosurg. Psychiatr., 73(5), 517–23CrossRef Google Scholar PubMed

Ghorayeb, I., Fernagut, P. O., Aubert, I.et al. (2000). Toward a primate model of L-dopa-unresponsive parkinsonism mimicking striatonigral degeneration. Mov. Disord., 15(3), 531–63.0.CO;2-C>CrossRef Google Scholar

Ghorayeb, I., Fernagut, P. O., Hervier, L., Labattu, B., Bioulac, B. & Tison, F. (2002a). A ‘single toxin-double lesion’ rat model of striatonigral degeneration by intrastriatal 1-methyl-4-phenylpyridinium ion injection: a motor behavioural analysis. Neuroscience, 115(2), 533–46CrossRef Google Scholar

Ghorayeb, I., Fernagut, P. O., Stefanova, N., Wenning, G. K., Bioulac, B. & Tison, F. (2002b). Dystonia is predictive of subsequent altered dopaminergic responsiveness in a chronic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine+3-nitropropionic acid model of striatonigral degeneration in monkeys. Neurosci. Lett., 335(1), 34–8CrossRef Google Scholar

Ghorayeb, I., Yekhlef, F., Chrysostome, V., Balestre, E., Bioulac, B. & Tison, F. (2002c). Sleep disorders and their determinants in multiple system atrophy. J. Neurol. Neurosurg. Psychiatr., 72(6), 798–800CrossRef Google Scholar

Giladi, N., Simon, E. S., Korczyn, A. D.et al. (2000). Anal sphincter EMG does not distinguish between multiple system atrophy and Parkinson's disease. Muscle Nerve, 23(5), 731–43.0.CO;2-#>CrossRef Google Scholar

Gilman, S., Koeppe, R. A., Junck, L., Kluin, K. J., Lohman, M. & St. Laurent, R. T. (1994). Patterns of cerebral glucose metabolism detected with positron emission tomography differ in multiple system atrophy and olivopontocerebellar atrophy. Ann. Neurol., 36, 166–75CrossRef Google Scholar PubMed

Gilman, S., Koeppe, R. A., Junck, L., Kluin, K. J., Lohman, M. & St. Laurent, R. T. (1995). Benzodiazepine receptor binding in cerebellar degenerations studied with positron emission tomography. Ann. Neurol., 38, 176–85CrossRef Google Scholar PubMed

Gilman, S., Sima, A. A., Junck, L., Kluin, K. J., Koeppe, R. A. & Lohman, M. E. & Little, R. (1996). Spinocerebellar ataxia type 1 with multiple system degeneration and glial cytoplasmic inclusions. Ann. Neurol., 39(2), 241–55CrossRef Google Scholar PubMed

Gilman, S., Low, P., Quinn, N.et al. (1998). Consensus statement on the diagnosis of multiple system atrophy. American Autonomic Society and American Academy of Neurology. Clin. Auton. Res., 8(6), 359–62CrossRef Google Scholar

Gilman, S., Low, P., Quinn, N.et al. (1999). Consensus statement on the diagnosis of multiple system atrophy. J. Neurol. Sci., 163(1), 94–8CrossRef Google Scholar

Gilman, S., Little, R., Johanns, J.et al. (2000). Evolution of sporadic olivopontocerebellar atrophy into multiple system atrophy. Neurology, 55(4), 527–32CrossRef Google Scholar PubMed

Goedert, M. & Spillantini, M. G. (1998). Lewy body diseases and multiple system atrophy as alpha-synucleinopathies. Mol. Psychiatr., 3(6), 462–5CrossRef Google Scholar PubMed

Gomez-Tortosa, E., Gonzalo, I., Newell, K., Yebenes, Garcia J., Vonsattel, P. & Hyman, B. T. (2002). Patterns of protein nitration in dementia with Lewy bodies and striatonigral degeneration. Acta Neuropathol. (Berl.), 103(5), 495–500CrossRef Google Scholar PubMed

Gonzalez-Quevedo, A., Garcia, J. C., Fernandez, R. & Cartaya, Fernandez L. (1993). Monoamine metabolites in normal human cerebrospinal fluid and in degenerative diseases of the central nervous system. Bol. Estud. Med. Biol., 41(1–4), 13–19Google Scholar PubMed

Gosset, A., Pellissier, J. F., Delpuech, F. & Khalil, R. (1983). Degenerescence striato-nigrique associée a une atrophie olivo-ponto-cerebelleuse. Rev. Neurol. (Paris., 139(2), 125–39Google Scholar

Goto, S., Hirano, A. & Matsumoto, S. (1989a). Subdivisional involvement of nigrostriatal loop in idiopathic Parkinson's disease and striatonigral degeneration. Ann. Neurol., 26(6), 766–70CrossRef Google Scholar

Goto, S., Hirano, A. & Rojas-Corona, R. R. (1989b). Calcineurin immunoreactivity in striatonigral degeneration. Acta Neuropathol. (Berl.), 78(1), 65–71CrossRef Google Scholar

Goto, S., Hirano, A. & Rojas-Corona, R. R. (1989c). Immunohistochemical visualization of afferent nerve terminals in human globus pallidus and its alteration in neostriatal neurodegenerative disorders. Acta. Neuropathol. (Berl.), 78(5), 543–50CrossRef Google Scholar

Goto, S., Hirano, A. & Matsumoto, S. (1990). Met-enkephalin immunoreactivity in the basal ganglia in Parkinson's disease and striatonigral degeneration. Neurology, 40(7), 1051–6CrossRef Google Scholar PubMed

Goto, S., Matsumoto, S., Ushio, Y. & Hirano, A. (1996). Subregional loss of putaminal efferents to the basal ganglia output nuclei may cause parkinsonism in striatonigral degeneration. Neurology, 47(4), 1032–6CrossRef Google Scholar PubMed

Gouider-Khouja, N., Vidailhet, M., Bonnet, A. M., Pichon, J. & Agid, Y. (1995). “Pure” striatonigral degeneration and Parkinson's disease: a comparative clinical study. Mov. Disord., 10(3), 288–94CrossRef Google Scholar PubMed

Graham, J. G. & Oppenheimer, D. R. (1969). Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy. J. Neurol. Neurosurg. Psychiatr., 32(1), 28–34CrossRef Google Scholar

Gu, M., Gash, M. T., Cooper, J. M.et al. (1997). Mitochondrial respiratory chain function in multiple system atrophy. Mov. Disord., 12(3), 418–22CrossRef Google Scholar PubMed

Hashida, H., Goto, J., Zhao, N.et al. (1998). Cloning and mapping of ZNF231, a novel brain-specific gene encoding neuronal double zinc finger protein whose expression is enhanced in a neurodegenerative disorder, multiple system atrophy (MSA). Genomics, 54, 50–8CrossRef Google Scholar

Hashimoto, M., Rockenstein, E., Mante, M., Mallory, M. & Masliah, E. (2001). Beta-synuclein inhibits alpha-synuclein aggregation: a possible role as an antiparkinsonian factor. Neuron, 32(2), 213–23CrossRef Google Scholar PubMed

Hayashi, M., Isozaki, E., Oda, M., Tanabe, H. & Kimura, J. (1997). Loss of large myelinated nerve fibres of the recurrent laryngeal nerve in patients with multiple system atrophy and vocal cord palsy. J. Neurol. Neurosurg. Psychiatr., 62(3), 234–8CrossRef Google Scholar PubMed

Hirsch, E. C., Hunot, S., Damier, P. & Faucheux, B. (1998). Glial cells and inflammation in Parkinson's disease: a role in neurodegeneration?Ann. Neurol., 44(3 Suppl 1), 115–20CrossRef Google Scholar PubMed

Holmberg, B., Rosengren, L., Karlsson, J. E. & Johnels, B. (1998). Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple-system atrophy compared with Parkinson's disease. Mov. Disord., 13(1), 70–7CrossRef Google Scholar PubMed

Holmberg, B., Johnels, B., Ingvarsson, P., Eriksson, B. & Rosengren, L. (2001). CSF-neurofilament and levodopa tests combined with discriminant analysis may contribute to the differential diagnosis of Parkinsonian syndromes. Parkinsonism Relat. Disord., 8(1), 23–31CrossRef Google Scholar

Horoupian, D. S. & Dickson, D. W. (1991). Striatonigral degeneration, olivopontocerebellar atrophy and “atypical” Pick disease. Acta Neuropathol. (Berl.), 81(3), 287–95CrossRef Google Scholar PubMed

Hu, M. T. M., Simmons, A., Glover, A.et al. (1998). Proton magnetic resonance spectroscopy of the putamen in Parkinson's disease and multiple system atrophy. Mov. Disord., 13, 182Google Scholar

Hughes, A. J., Colosimo, C., Kleedorfer, B., Daniel, S. E. & Lees, A. J. (1992). The dopaminergic response in multiple system atrophy. J. Neurol. Neurosurg. Psychiatr., 55(11), 1009–13CrossRef Google Scholar PubMed

Hughes, A. J., Daniel, S. E., Ben-Shlomo, Y. & Lees, A. J. (2002). The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain, 125(4), 861–70CrossRef Google Scholar

Hughes, R. G., Gibbin, K. P. & Lowe, J. (1998). Vocal fold abductor paralysis as a solitary and fatal manifestation of multiple system atrophy. J. Laryng. Otol., 112(2), 177–8CrossRef Google Scholar PubMed

Hunot, S., Dugas, N., Faucheux, B.et al. (1999). Fc-epsilon RII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells. J. Neurosci., 19(9), 3440–7CrossRef Google Scholar PubMed

Hussain, I. F., Brady, C. M., Swinn, M. J., Mathias, C. J. & Fowler, C. J. (2001). Treatment of erectile dysfunction with sildenafil citrate (Viagra) in parkinsonism due to Parkinson's disease or multiple system atrophy with observations on orthostatic hypotension. J. Neurol. Neurosurg. Psychiatr., 71, 371–4CrossRef Google Scholar PubMed

Ichikawa, N. (1986). Study on monoamine metabolite contents of cerebrospinal fluid in patients with neurodegenerative diseases. Tohoku J. Exp. Med., 150(4), 435–46CrossRef Google Scholar PubMed

Iranzo, A., Santamaria, J. & Tolosa, E. (2000). Continuous positive air pressure eliminates nocturnal stridor in multiple system atrophy. Barcelona Multiple System Atrophy Study Group. The Lancet, 356, 1329–30CrossRef Google Scholar PubMed

Ito, H., Kusaka, H., Matsumoto, S. & Imai, T. (1996). Striatal efferent involvement and its correlation to levodopa efficacy in patients with multiple system atrophy. Neurology, 47(5), 1291–9CrossRef Google Scholar PubMed

Iwahashi, K., Miyatake, R., Tsuneoka, Y.et al. (1995). A novel cytochrome P-450IID6 (CYPIID6) mutant gene associated with multiple system atrophy. J. Neurol. Neurosurg. Psychiatr., 58(2), 263–4CrossRef Google Scholar PubMed

Jankovic, J., Gilden, J. L., Hiner, B. C.et al. (1993a). Neurogenic orthostatic hypotension: a double-blind, placebo-controlled study with midodrine. Am. J. Med., 95, 38–48CrossRef Google Scholar

Jankovic, J., Rajput, A. H., Golbe, L. & Goodman, J. C. (1993b). What is it? Case 1. Parkinsonism, dysautonomia, and ophthalmoparesis. Mov. Disord., 8, 525–32CrossRef Google Scholar

Jaros, E. & Burn, D. J. (2000). The pathogenesis of multiple system atrophy: past, present and future. Mov. Disord., 15(5), 784–83.0.CO;2-P>CrossRef Google Scholar

Johnsen, J. A. & Miller, V. T. (1986). Tobacco intolerance in multiple system atrophy. Neurology, 36, 986–8CrossRef Google Scholar PubMed

Kahle, P. J., Neumann, M., Ozmen, L.et al. (2002). Hyperphosphorylation and insolubility of alpha-synuclein in transgenic mouse oligodendrocytes. EMBO Rep., 3(6), 583–8CrossRef Google Scholar PubMed

Kan, A. E. (1978). Striatonigral degeneration. Pathology, 10(1), 45–52CrossRef Google Scholar PubMed

Kato, S., Oda, M., Hayashi, H.et al. (1995). Decrease of medullary catecholaminergic neurons in multiple system atrophy and Parkinson's disease and their preservation in amyotrophic lateral sclerosis. J. Neurol. Sci., 132(2), 216–21CrossRef Google Scholar PubMed

Kaufmann, H., Oribe, E., Miller, M., Knott, P., Wiltshire-Clement, M. & Yahr, M. D. (1992). Hypotension-induced vasopressin release distinguishes between pure autonomic failure and multiple system atrophy with autonomic failure. Neurology, 42(3), 590–3CrossRef Google Scholar PubMed

Kawamoto, Y., Nakamura, S., Akiguchi, I. & Kimura, J. (1999). Increased brain-derived neurotrophic factor-containing axons in the basal ganglia of patients with multiple system atrophy. J. Neuropathol. Exp. Neurol., 58(7), 765–72CrossRef Google Scholar PubMed

Kew, J., Gross, M. & Chapman, P. (1990). Shy–Drager syndrome presenting as isolated paralysis of vocal cord abductors. Br. Med. J., 300, 1441CrossRef Google Scholar PubMed

Kihara, M., Suganoya, J. & Takahashi, A. (1991). The assessment of sudomotor dysfunction in multiple system atrophy. Clin. Auton. Res., 1, 297–302CrossRef Google Scholar PubMed

Kikuchi, A., Takeda, A., Onodera, H.et al. (2002). Systemic increase of oxidative nucleic acid damage in Parkinson's disease and multiple system atrophy. Neurobiol. Dis., 9(2), 244–8CrossRef Google Scholar PubMed

Kim, Y. J., Ichise, M., Ballinger, J. R.et al. (2002). Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP. Mov. Disord., 17(2), 303–12CrossRef Google Scholar PubMed

Kimber, J. R., Watson, L. & Mathias, C. J. (1997). Distinction of idiopathic Parkinson's disease from multiple system atrophy by stimulation of growth-hormone release with clonidine. The Lancet, 349, 1877–81CrossRef Google Scholar PubMed

Kimber, J., Watson, L. & Mathias, C. J. (1999a). Abnormal suppression of arginine-vasopressin by clonidine in multiple system atrophy. Clin. Auton. Res., 9(5), 271–4CrossRef Google Scholar

Kimber, J., Watson, L. & Mathias, C. J. (1999b). Neuroendocrine responses to levodopa in multiple system atrophy (MSA). Mov. Disord., 14(6), 981–73.0.CO;2-W>CrossRef Google Scholar

Kimber, J., Mathias, C. J., Lees, A. J.et al. (2000). Physiological, pharmacological and neurohormonal assessment of autonomic function in progressive supranuclear palsy. Brain, 123(7), 1422–30CrossRef Google Scholar PubMed

Kirby, R., Fowler, C. J., Gosling, J. & Bannister, R. (1986). Urethro-vesical dysfunction in progressive autonomic failure with multiple system atrophy. J. Neurol. Neurosurg. Psychiatr., 49, 554–62CrossRef Google Scholar PubMed

Kiyosawa, K., Mokuno, K., Murakami, N.et al. (1993). Cerebrospinal fluid 28-kDa calbindin-D as a possible marker for Purkinje cell damage. J. Neurol. Sci., 118(1), 29–33CrossRef Google Scholar PubMed

Klein, C., Wenning, G. K. & Quinn, N. P. (1995). Pseudotransitory ischemic attacks as the initial symptom of multiple system atrophy. Nervenarzt, 66(2), 133–5Google Scholar PubMed

Klein, C., Brown, R., Wenning, G. & Quinn, N. (1997). The “cold hand sign” in multiple system atrophy. Mov. Disord., 12(4), 514–18CrossRef Google Scholar

Klockgether, T., Schroth, G., Diener, H. C. & Dichgans, J. (1990). Idiopathic cerebellar ataxia of late onset: natural history and MRI morphology. J. Neurol. Neurosurg. Psychiatr., 53, 297–305CrossRef Google Scholar PubMed

Kluin, K. J., Gilman, S., Lohmann, M. & Junck, L. (1996). Characteristics of the dysarthria of multiple system atrophy. Arch. Neurol., 53, 545–8CrossRef Google Scholar PubMed

Kofler, M., Müller, J., Wenning, G. K.et al. (2001). The auditory startle reaction in parkinsonian disorders. Mov. Disord., 16(1), 62–713.0.CO;2-V>CrossRef Google Scholar PubMed

Kofler, M., Muller, J., Seppi, K. & Wenning, G. K. (2003). Exaggerated auditory startle responses in multiple system atrophy: a comparative study of parkinson and cerebellar subtypes. Clin. Neurophysiol., 114(3), 541–7CrossRef Google Scholar PubMed

Konagaya, M., Konagaya, Y., Honda, H. & Iida, M. (1993). A clinico-MRI study of extrapyramidal symptoms in multiple system atrophy – linear hyperintensity in the outer margin of the putamen. No To Shinkei, 45(6), 509–13Google Scholar PubMed

Konagaya, M., Konagaya, Y. & Iida, M. (1994). Clinical and magnetic resonance imaging study of extrapyramidal symptoms in multiple system atrophy. J. Neurol. Neurosurg. Psychiatr., 57, 1528–31CrossRef Google Scholar PubMed

Konagaya, M., Sakai, M., Matsuoka, Y., Goto, Y., Yoshida, M. & Hashizume, Y. (1998). Patho-MR imaging study in the putaminal margin in multiple system atrophy. No To Shinkei, 50(4), 383–5Google Scholar PubMed

Konagaya, M., Sakai, M., Matsuoka, Y., Konagaya, Y. & Hashizume, Y. (1999). Multiple system atrophy with remarkable frontal lobe atrophy. Acta Neuropathol. (Berl.), 97(4), 423–8CrossRef Google Scholar PubMed

Konagaya, M., Konagaya, Y., Sakai, M., Matsuoka, Y. & Hashizume, Y. (2002). Progressive cerebral atrophy in multiple system atrophy. J. Neurol. Sci., 195(2), 123–7CrossRef Google Scholar PubMed

Konings, C. H., Kuiper, M. A., Teerlink, T., Mulder, C., Scheltens, P. & Wolters, E. C. (1999). Normal cerebrospinal fluid glutathione concentrations in Parkinson's disease, Alzheimer's disease and multiple system atrophy. J. Neurol. Sci., 168(2), 112–15CrossRef Google Scholar PubMed

Konno, H., Yamamoto, T., Iwasaki, Y. & Iizuka, H. (1986). Shy–Drager syndrome and amyotrophic lateral sclerosis. Cytoarchitectonic and morphometric studies of sacral autonomic neurons. J. Neurol. Sci., 73(2), 193–204CrossRef Google Scholar PubMed

Kraft, E., Schwarz, J., Trenkwalder, C., Vogl, T., Pfluger, T. & Oertel, W. H. (1999). The combination of hypointense and hyperintense signal changes on T2-weighted magnetic resonance imaging sequences: a specific marker of multiple system atrophy?Arch. Neurol., 56(2), 225–8CrossRef Google Scholar PubMed

Kraft, E., Trenkwalder, C. & Auer, D. P. (2002). T2*-weighted MRI differentiates multiple system atrophy from Parkinson's disease. Neurology, 59(8), 1265–7CrossRef Google Scholar PubMed

Krüger, R., Kuhn, W., Muller, T.et al. (1998). Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat. Genet., 18(2), 106–8CrossRef Google Scholar PubMed

Krüger, R., Vieira-Saecker, A. M., Kuhn, W.et al. (1999). Increased susceptibility to sporadic Parkinson's disease by a certain combined alpha-synuclein/apolipoprotein E genotype. Ann. Neurol., 45(5), 611–173.0.CO;2-X>CrossRef Google Scholar PubMed

Kuiper, M. A., Visser, J. J., Bergmans, P. L., Scheltens, P. & Wolters, E. C. (1994). Decreased cerebrospinal fluid nitrate levels in Parkinson's disease, Alzheimer's disease and multiple system atrophy patients. J. Neurol. Sci., 121(2), 46–9CrossRef Google Scholar PubMed

Kuiper, M. A., Teerlink, T., Visser, J. J., Bergmans, P. L., Scheltens, P. & Wolters, E. C. (2000). L-glutamate, L-arginine and L-citrulline levels in cerebrospinal fluid of Parkinson's disease, multiple system atrophy, and Alzheimer's disease patients. J. Neural Transm., 107(2), 183–9CrossRef Google Scholar PubMed

Kume, A., Takahashi, A. & Hashizume, Y. (1993). Neuronal cell loss of the striatonigral system in multiple system atrophy. J. Neurol. Sci., 117(1–2), 33–40CrossRef Google Scholar PubMed

Lambie, C. G., Latham, O. & Mac Donald, G. L. (1947). Olivo-ponto-cerebellar atrophy (Marie's ataxia). Med. J. Aust., 2, 626–32Google Scholar

Lang, A. E., Curran, T., Provias, J. & Bergeron, C. (1994). Striatonigral degeneration: iron deposition in putamen correlated with the slit-like void signal of magnetic resonance imaging. Can. J. Neurol. Sci., 21, 311–18CrossRef Google Scholar

Lang, A. E., Lozano, A., Duff, J.et al. (1997). Medial pallidotomy in late-stage Parkinson's disease and striatonigral degeneration. Adv. Neurol., 74, 199–211Google Scholar PubMed

Langston, W. (1936). Orthostatic hypotension: report of a case. Ann. Int. Med., 10, 688–95Google Scholar

Lantos, P. L. (1998). The definition of multiple system atrophy: a review of recent developments. J. Neuropathol. Exp. Neurol., 57, 1099–111CrossRef Google Scholar PubMed

Lees, A. J. (1999). The treatment of the motor disorders of multiple system atrophy. In Autonomic Failure, ed. C. J. Mathias & R. Bannister. Oxford: Oxford University Press, pp. 357–63

Lees, A. J. & Bannister, R. (1981). The use of lisuride in the treatment of multiple system atrophy with autonomic failure (Shy Drager syndrome). J. Neurol. Neurosurg. Psychiatr., 44, 347–51CrossRef Google Scholar

Leggo, J., Dalton, A., Morrison, P. J.et al. (1997). Analysis of spinocerebellar ataxia types 1,2,3, and 6, dentatorubral-pallidoluysian atrophy, and Friedreich's ataxia genes in spinocerebellar ataxia patients in the UK. J. Med. Genet., 34(12), 982–5CrossRef Google Scholar PubMed

Libelius, R. & Johannson, F. (2000). Quantitative electromyography of the external anal sphincter in Parkinson's disease and multiple system atrophy. Muscle Nerve, 23(8), 1250–63.0.CO;2-W>CrossRef Google Scholar PubMed

Lindsay, R. M., Wiegand, S. J., Altar, C. A. & DiStefano, P. S. (1994). Neurotrophic factors: from molecule to man. Trends Neurosci., 17(5), 182–90CrossRef Google Scholar

Litvan, I., Agid, Y., Calne, D.et al. (1996). Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele–Richardson–Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology, 47(1), 1–9CrossRef Google Scholar

Litvan, I., Goetz, C. G., Jankovic, J.et al. (1997). What is the accuracy of the clinical diagnosis of multiple system atrophy? A clinicopathologic study. Arch. Neurol., 54(8), 937–44CrossRef Google Scholar PubMed

Litvan, I., Booth, V., Wenning, G. K.et al. (1998). Retrospective application of a set of clinical diagnostic criteria for the diagnosis of multiple system atrophy. J. Neural Transm., 105(2–3), 217–27CrossRef Google Scholar

Low, P. A., Gilden, J. L., Freeman, R., Sheng, K. N. & McElligott, M. A. (1997). Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. Midodrine Study Group. J. Ann. Med. Assoc., 277, 1046–51CrossRef Google Scholar PubMed

Magalhães, M., Wenning, G. K., Daniel, S. E. & Quinn, N. P. (1995). Autonomic dysfunction in pathologically confirmed multiple system atrophy and idiopathic Parkinson's disease – a retrospective comparison. Acta Neurol. Scand., 91, 98–102CrossRef Google Scholar PubMed

Mallipeddi, R. & Mathias, C. J. (1988). Raynaud's phenomenon after sympathetic denervation in patients with primary autonomic failure: questionnaire survey. Br. Med. J., 316(7129), 438–9CrossRef Google Scholar

Martignoni, E., Blandini, F., Petraglia, F., Pacchetti, C., Bono, G. & Nappi, G. (1992). Cerebrospinal fluid norepinephrine, 3-methoxy-4-hydroxyphenylglycol and neuropeptide Y levels in Parkinson's disease, multiple system atrophy and dementia of the Alzheimer type. J. Neural Transm. Park Dis., Dement. Sect., 4(3), 191–205CrossRef Google Scholar PubMed

Martinelli, P. & Coccagna, G. (1978). Etude electromyographique du sphincter strie de l'anus dans trois cas de syndrome de Shy-Drager. In Electromyographie, ed. L. Arbus & J. Cadilhac. Toulouse: Premières Journées Languedociènnes d'Electromyographie, 321–6

Mathias, C. J. & Kimber, J. R. (1999). Postural hypotension: causes, clinical features, investigation, and management. Annu. Rev. Med., 50, 317–36CrossRef Google Scholar PubMed

Mathias, C. J., Fosbraey, P., da Costa, D. F., Thornley, A. & Bannister, R. (1986). The effect of desmopressin on nocturnal polyuria, overnight weight loss, and morning postural hypotension in patients with autonomic failure. Br. Med. J. (Clin. Res. Ed.), 293, 353–4CrossRef Google Scholar PubMed

Mathias, C. J., Senard, J. M., Braune, S.et al. (2001). L-threo-dihydroxyphenylserine (L-threo-DOPS; droxidopa) in the management of neurogenic orthostatic hypotension: a multi-national, multi-center, dose-ranging study in multiple system atrophy and pure autonomic failure. Clin. Auton. Res., 11(4), 235–42CrossRef Google Scholar PubMed

McGuire, S. O., Ling, Z. D., Lipton, J. W., Sortwell, C. E., Collier, T. J. & Carvey, P. M. (2001). Tumor necrosis factor alpha is toxic to embryonic mesencephalic dopamine neurons. Exp. Neurol., 169(2), 219–30CrossRef Google Scholar PubMed

Meco, G., Gasparini, M. & Doricchi, F. (1996). Attentional functions in multiple system atrophy and Parkinson's disease. J. Neurol. Neurosurg. Psychiatr., 60, 393–8CrossRef Google Scholar PubMed

Merlo, I. M., Occhini, A., Pacchetti, C. & Alfonsi, E. (2002). Not paralysis, but dystonia causes stridor in multiple system atrophy. Neurology, 58(4), 649–52CrossRef Google Scholar PubMed

Mizutani, T., Satoh, J. & Morimatsu, Y. (1988). Neuropathological background of oculomotor disturbances in olivopontocerebellar atrophy with special reference to slow saccade. Clin. Neuropathol., 7(2), 53–61Google Scholar PubMed

Mogi, M., Harada, M., Riederer, P., Narabayashi, H., Fujita, K. & Nagatsu, T. (1994). Tumor necrosis factor alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients. Neurosci. Lett., 165(1–2), 208–10CrossRef Google Scholar PubMed

Montagna, P., Martinelli, P., Rizzuto, N., Salviati, A., Rasi, F. & Lugaresi, E. (1983). Amyotrophy in Shy–Drager syndrome. Acta Neurol. Belg., 83, 142–57Google Scholar PubMed

Morris, H. R., Vaughan, J. R., Datta, S. R.et al. (2000). Multiple system atrophy/progressive supranuclear palsy: alpha-synuclein, synphilin, tau, and APOE. Neurology, 55(12), 1918–20CrossRef Google Scholar PubMed

Moseley, M. L., Benzow, K. A., Schut, L. J.et al. (1998). Incidence of dominant spinocerebellar and Friedreich triplet repeats among 361 ataxia families. Neurology, 51(6), 1666–71CrossRef Google Scholar PubMed

Müller, J., Wenning, G. K., Jellinger, K., McKee, A., Poewe, W. & Litvan, I. (2000). Progression of Hoehn and Yahr stages in parkinsonian disorders: a clinicopathologic study. Neurology, 55(6), 888–91CrossRef Google Scholar PubMed

Müller, J., Wenning, G. K., Verny, M.et al. (2001). Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders. Arch. Neurol., 58(2), 259–64CrossRef Google Scholar PubMed

Murer, M. G., Yan, Q. & Raisman-Vozari, R. (2000). Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease. Prog. Neurobiol., 63(1), 71–124CrossRef Google Scholar

Nakamura, S., Ohnishi, K., Nishimura, M.et al. (1996). Large neurons in the tuberomammillary nucleus in patients with Parkinson's disease and multiple system atrophy. Neurology, 46(6), 1693–6CrossRef Google Scholar PubMed

Nakamura, T., Yamashita, H., Takahashi, T. & Nakamura, S. (2001). Activated Fyn phosphorylates alpha-synuclein at tyrosine residue 125. Biochem. Biophys. Res. Commun., 280(4), 1085–92CrossRef Google Scholar PubMed

Nee, L. E., Gomez, M. R., Dambrosia, J., Bale, S., Eldridge, R. & Polinsky, R. J. (1991). Environmental – occupational risk factors and familial associations in multiple system atrophy: a preliminary investigation. Clin. Auton. Res., 1(1), 9–13CrossRef Google Scholar PubMed

Negro, A., Brunati, A. M., Donella-Deana, A., Massimino, M. L. & Pinna, L. A. (2002). Multiple phosphorylation of alpha-synuclein by protein tyrosine kinase Syk prevents cosin-induced aggregation. FASEB J., 16(2), 210–12CrossRef Google Scholar PubMed

Neumann, M. A. (1977). Pontocerebellar atrophy combined with vestibular-reticular degeneration. J. Neuropathol. Exp. Neurol., 36(2), 321–37CrossRef Google Scholar PubMed

Nicholl, D. J., Bennett, P., Hiller, L.et al. (1999). A study of five candidate genes in Parkinson's disease and related neurodegenerative disorders. European Study Group on Atypical Parkinsonism. Neurology, 53(7), 1415–21CrossRef Google Scholar

Nutt, J. G., Mrox, E. A., Leeman, S. E., Williams, A. C., Engel, W. K. & Chase, T. N. (1980). Substance P in human cerebrospinal fluid: reductions in peripheral neuropathy and autonomic dysfunction. Neurology, 30(12), 1280–5CrossRef Google Scholar PubMed

O'Brien, C., Sung, J. H., McGeachie, R. E. & Lee, M. C. (1990). Striatonigral degeneration: clinical, MRI, and pathologic correlation. Neurology, 40(4), 710–11Google Scholar PubMed

Oertel, W. H., Wachter, T., Quinn, N. P., Ulm, G. & Brandstadter, D. (2003). Reduced genital sensitivity in female patients with multiple system atrophy of parkinsonian type. Mov. Disord., 18(4), 430–2CrossRef Google Scholar PubMed

Olanow, C. W. (1992). Magnetic resonance imaging in parkinsonism. Neurol. Clin., 10, 405–420CrossRef Google Scholar PubMed

Olanow, C. W. & Tatton, W. G. (1999). Etiology and pathogenesis of Parkinson's disease. Annu. Rev. Neurosci., 22, 123–44CrossRef Google Scholar PubMed

Oppenheimer, D. R. (1980). Lateral horn cells in progressive autonomic failure. J. Neurol. Sci., 46(3), 393–404CrossRef Google Scholar PubMed

Orimo, S., Ozawa, E., Nakade, S., Sugimoto, T. & Mizusawa, H. (1999). (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease. J. Neurol. Neurosurg. Psychiatr., 67(2), 189–94CrossRef Google Scholar PubMed

Orozco, G., Estrada, R., Perry, T. L.et al. (1989). Dominantly inherited olivopontocerebellar atrophy from eastern Cuba. Clinical, neuropathological, and biochemical findings. J. Neurol. Sci., 93(1), 37–50CrossRef Google Scholar PubMed

Osaki, Y., Wenning, G. K., Daniel, S. E.et al. (2002). Do published criteria improve clinical diagnostic accuracy in multiple system atrophy?Neurology, 59(10), 1486–91CrossRef Google Scholar PubMed

Ostrerova, N., Petrucelli, L., Farrer, M.et al. (1999). alpha-synuclein shares physical and functional homology with 14-3-3 proteins. J. Neurosci., 19(14), 5782–91CrossRef Google Scholar PubMed

Ozaki, M., Sasner, M., Yano, R., Lu, H. S. & Buonanno, A. (1997). Neuregulin-beta induces expression of an NMDA-receptor subunit. Nature, 390(6661), 691–4CrossRef Google Scholar PubMed

Ozawa, T., Takano, H., Onodera, O.et al. (1999). No mutation in the entire coding region of the alpha-synuclein gene in pathologically confirmed cases of multiple system atrophy. Neurosci. Lett., 270(2), 110–12CrossRef Google Scholar PubMed

Ozawa, T., Okuizumi, K., Ikeuchi, T., Wakabayashi, K., Takahashi, H. & Tsuji, S. (2001). Analysis of the expression level of alpha-synuclein mRNA using post-mortem brain samples from pathologically confirmed cases of multiple system atrophy. Acta Neuropathol.(Berl.), 102(2), 188–90Google Scholar

Palace, J., Chandiramani, V. A. & Fowler, C. J. (1997). Value of sphincter electromyography in the diagnosis of multiple system atrophy. Muscle & Nerve, 20(11), 1396–4033.0.CO;2-5>CrossRef Google Scholar

Papp, M. I. & Lantos, P. L. (1992). Accumulation of tubular structures in oligodendroglial and neuronal cells as the basic alteration in multiple system atrophy. J. Neurol. Sci., 107(2), 172–82CrossRef Google Scholar PubMed

Papp, M. I. & Lantos, P. L. (1994). The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology. Brain, 117(2), 235–43CrossRef Google Scholar PubMed

Papp, M. I., Kahn, J. E. & Lantos, P. L. (1989). Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy–Drager syndrome). J. Neurol. Sci., 94(1–3), 79–100CrossRef Google Scholar

Parati, E. A., Fetoni, V., Geminiani, G. C.et al. (1993). Response to L-Dopa in multiple system atrophy. Clin. Neuropharmacol., 16(2), 139–44CrossRef Google Scholar PubMed

Pastakia, B., Polinsky, R., Di Chiro, G.et al. (1989). Multiple system atrophy (Shy–Drager syndrome): MR imaging. Radiology, 159, 499–502CrossRef Google Scholar

Pellecchia, M. T., Salvatore, E., Pivonello, R.et al. (2001). Stimulation of growth hormone release in multiple system atrophy, Parkinson's disease and idiopathic cerebellar ataxia. Neurol. Sci., 22(1), 79–80CrossRef Google Scholar PubMed

Perani, D., Bressi, S., Testa, D.et al. (1995). Clinical/metabolic correlations in multiple system atrophy. A fludeoxyglucose F18 Positron Emission Tomography Study. Arch. Neurol., 52, 179–85CrossRef Google Scholar

Perera, R., Isola, L. & Kaufmann, H. (1995). Effect of recombinant erythropoietin on anaemia and orthostatic hypotension in primary autonomic failure. Clin. Auton. Res., 5(4), 211–13CrossRef Google Scholar PubMed

Perez, D. (2001). Overstimulation of the alpha1B-adrenergic receptor causes a “seizure plus” syndrome. Nat. Med., 7(2), 132–3CrossRef Google Scholar

Pillon, B., Gouider-Khouja, N., Deweer, B.et al. (1995). Neuropsychological pattern of striatonigral degeneration: comparison with Parkinson's disease and progressive supranuclear palsy. J. Neurol. Neurosurg. Psychiatr., 58, 174–9CrossRef Google Scholar

Pirker, W., Asenbaum, S., Bencsits, G.et al. (2000). (123I)beta-CIT SPECT in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration. Mov. Disord., 15(6), 1158–673.0.CO;2-0>CrossRef Google Scholar PubMed

Pirker, W., Djamshidian, S., Asenbaum, S.et al. (2002). Progression of dopaminergic degeneration in Parkinson's disease and atypical parkinsonism: a longitudinal beta-CIT SPECT study. Mov. Disord., 17(1), 45–53CrossRef Google Scholar PubMed

Plaitakis, A., Flessas, P., Natsiou, A. B. & Shashidharan, P. (1993). Glutamate dehydrogenase deficiency in cerebellar degenerations: clinical, biochemical and molecular genetic aspects. Can. J. Neurol. Sci., 20(Suppl 3), S109–16Google Scholar PubMed

Plazzi, G., Corsini, R. & Provini, F. (1997). REM sleep behavior disorders in multiple system atrophy. Neurology, 48, 1094–7CrossRef Google Scholar PubMed

Polinsky, R. J., Brown, R. T., Lee, G. K.et al. (1987). Beta-endorphin, ACTH, and catecholamine responses in chronic autonomic failure. Ann. Neurol., 21(6), 573–7CrossRef Google Scholar PubMed

Polinsky, R. J., Kopin, I. J., Ebert, M. H. & Weise, V. (1981). Pharmacologic distinction of different orthostatic hypotension syndromes. Neurology, 31(1), 1–7CrossRef Google Scholar PubMed

Polinsky, R. J., Taylor, I. L., Chew, P., Weise, V. & Kopin, L. J. (1982). Pancreatic polypeptide responses to hypoglycaemia in chronic autonomic failure. J. Clin. Endocrinol. Metab., 54(1), 48–52CrossRef Google Scholar PubMed

Polinsky, R. J., McRae, A., Baser, S. M. & Dahlstrom, A. (1991). Antibody in the CSF of patients with multiple system atrophy reacts specifically with rat locus ceruleus. Neurol. Sci., 106(1), 96–104CrossRef Google Scholar PubMed

Polymeropoulos, M. H., Lavedan, C., Leroy, E.et al. (1997). Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science, 276(5321), 2045–7CrossRef Google Scholar PubMed

Powell, S. K., Williams, C. C., Nomizu, M., Yamada, Y. & Kleinman, H. K. (1998). Laminin-like proteins are differentially regulated during cerebellar development and stimulate granule cell neurite outgrowth in vitro. J. Neurosci. Res., 54(2), 233–473.0.CO;2-5>CrossRef Google Scholar PubMed

Pramstaller, P., Wenning, G. K., Smith, S. J. M., Beck, R. O., Quinn, N. P. & Fowler, C. J. (1995). Nerve conduction studies, skeletal muscle EMG, and sphincter EMG in multiple system atrophy. J. Neurol. Neurosurg. Psychiatr., 58, 618–21CrossRef Google Scholar PubMed

Price, R. H., Albin, R. L., Sakurai, S. Y., Polinsky, R. J., Penney, J. B. & Young, A. B. (1993). Cerebellar excitatory and inhibitory amino acid receptors in multiple system atrophy. Neurology, 43(7), 1323–8CrossRef Google Scholar PubMed

Quik, M., Spokes, E. G., Mackay, A. V. & Bannister, R. (1979). Alterations in [3H]spiperone binding in human caudate nucleus, substantia nigra and frontal cortex in the Shy–Drager syndrome and Parkinson's disease. J. Neurol. Sci., 43(3), 429–37CrossRef Google Scholar

Quinn, N. (1989a). Disproportionate antecollis in multiple system atrophy. Lancet, 1(8642), 844CrossRef Google Scholar

Quinn, N. (1989b). Multiple system atrophy – the nature of the beast. J. Neurol. Neurosurg. Psychiatr., 52(Suppl.), 78–89CrossRef Google Scholar

Quinn, N. (1994). Multiple system atrophy. In Movement Disorders 3, ed. C. D. Marsden & S. Fahn. London: Butterworth-Heinemann, pp. 262–81

Quinn, N. P., Wenning, G. & Marsden, C. D. (1995). The Shy–Drager syndrome. What did Shy and Drager really describe?Arch. Neurol., 52(7), 656–7CrossRef Google Scholar PubMed

Raabe, T. D., Suy, S., Welcher, A. & DeVries, G. H. (1997). Effect of neu differentiation factor isoforms on neonatal oligodendrocyte function. J. Neurosci. Res., 50(5), 755–683.0.CO;2-0>CrossRef Google Scholar PubMed

Raimbach, S. J., Cortelli, P., Kooner, J. S., Bannister, R., Bloom, S. R. & Mathias, C. J. (1989). Prevention of glucose-induced hypotension by the somatostatin analogue octreotide (SMS 201–995) in chronic autonomic failure: haemodynamic and hormonal changes. Clin. Sci. (Lond.), 77, 623–8CrossRef Google Scholar PubMed

Rajput, A. H., Rozdilsky, B., Rajput, A. & Ang, L. (1990). Levodopa efficacy and pathological basis of Parkinson syndrome. Clin. Neuropharmacol., 13(6), 553–8CrossRef Google Scholar PubMed

Ranum, L. P., Lundgren, J. K., Schut, L. J.et al. (1995). Spinocerebellar ataxia type 1 and Machado–Joseph-disease: incidence of CAG expansions among adult-onset ataxia patients from 311 families with dominant, recessive, or sporadic ataxia. Am. J. Hum. Genet., 57(3), 603–8Google Scholar PubMed

Rascol, O., Sabatini, U., Simonetta-Moreau, M., Montastruc, J. L., Rascol, A. & Clanet, M. (1991). Square wave jerks in Parkinsonian syndromes. J. Neurol. Neurosurg. Psychiatr., 54, 599–602CrossRef Google Scholar PubMed

Rascol, O., Sabatini, U., Fabre, N.et al. (1995). Abnormal vestibuloocular reflex cancellation in multiple system atrophy and progressive supranuclear palsy but not in Parkinson's disease. Mov. Disord., 10(2), 163–70CrossRef Google Scholar PubMed

Riley, D. E. & Chelimsky, T. C. (2003). Autonomic nervous system testing may not distinguish multiple system atrophy from Parkinson's disease. J. Neurol. Neurosurg. Psychiatr., 74(1), 56–60CrossRef Google Scholar

Rinne, J. O., Burn, D. J., Mathias, C. J., Quinn, N. P., Marsden, C. D. & Brooks, D. J. (1995). Positron emission tomography studies on the dopaminergic system and striatal opioid binding in the olivopontocerebellar atrophy variant of multiple system atrophy. Ann. Neurol., 37, 568–73CrossRef Google Scholar PubMed

Rivest, J., Quinn, N. & Marsden, C. D. (1990). Dystonia in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. Neurology, 40, 1571–8CrossRef Google Scholar PubMed

Robbins, T. W., James, M., Lange, K. W., Owen, A. M., Quinn, N. P. & Marsden, C. D. (1992). Cognitive performance in multiple system atrophy. Brain, 115(1), 271–91CrossRef Google Scholar PubMed

Sakakibara, R., Hattori, T., Uchiyama, T.et al. (2000a). Urinary dysfunction and orthostatic hypotension in multiple system atrophy: which is the more common and earlier manifestation?J. Neurol. Neurosurg. Psychiatr., 68(1), 65–9CrossRef Google Scholar

Sakakibara, R., Hattori, T., Uchiyama, T.et al. (2000b). Are alpha-blockers involved in lower urinary tract dysfunction in multiple system atrophy? A comparison of prazosin and moxisylyte. J. Auton. Nerv. Syst., 79, 191–5CrossRef Google Scholar

Salazar, G., Valls-Sole, J., Marti, M. J., Chang, H. & Tolosa, E. S. (2000). Postural and action myoclonus in patients with parkinsonian type of multiple system atrophy. Mov. Disord., 15(1), 77–833.0.CO;2-N>CrossRef Google Scholar PubMed

Sandroni, P., Ahlskog, J. E., Fealy, R. D. & Low, P. A. (1991). Autonomic involvement in extrapyramidal and cerebellar disorders. Clin. Auton. Res., 1, 147–55CrossRef Google Scholar PubMed

Santens, P., Crevits, L. & Linden, C. (1996). Raynaud's phenomenon in a case of multiple system atrophy. Mov. Disord., 11, 586–8CrossRef Google Scholar

Satoh, J. I. & Kuroda, Y. (2001). Alpha-synuclein expression is up-regulated in NTera2 cells during neuronal differentiation but unaffected by exposure to cytokines and neurotrophic features. Parkinsonism Relat. Disord., 8(1), 7–17CrossRef Google Scholar

Savoiardo, M., Strada, L. & Girotti, F. (1990). Olivopontocerebellar atrophy: MR diagnosis and relationship to multisystem atrophy. Radiology, 174, 693–6CrossRef Google Scholar PubMed

Schelhaas, H. J., Hageman, G. & Post, J. G. (1997). Cerebellar ataxia, dementia, pyramidal signs, cortical cataract of the posterior pole and a raised IgG index in a patient with a sporadic form of olivopontocerebellar atrophy. Clin. Neurol. Neurosurg., 99(2), 99–101CrossRef Google Scholar

Schelosky, L., Hierholzer, J., Wissel, J., Cordes, M. & Poewe, W. (1993). Correlation of clinical response in apomorphine test with D2-receptor status as demonstrated by 123I IBZM-SPECT. Mov. Disord., 8(4), 453–8CrossRef Google Scholar PubMed

Scherer, H. J. (1933a). Beiträge zur pathologischen Anatomie des Kleinhirns. III. Mitteilung: Genuine Kleinhirnatrophien. Z. Gesamte. Neurol. Psychiatri., 145, 335–405CrossRef Google Scholar

Scherer, H. J. (1933b). Extrapyramidale Störungen bei der olivopontocerebellären Atrophie. Z. Gesamte. Neurol. Psychiatri., 145, 406–19CrossRef Google Scholar

Scherfler, C., Puschban, Z., Ghorayeb, I.et al. (2000). Complex motor disturbances in a sequential double lesion rat model of striatonigral degeneration (multiple system atrophy). Neuroscience, 99(1), 43–54CrossRef Google Scholar

Schocke, M., Seppi, K., Esterhammer, R.et al. (2002). Diffusion-weighted MRI differentiates the Parkinson variant of multiple system atrophy from PD. Neurology, 58(4), 575–80CrossRef Google Scholar PubMed

Schöls, L., Szymanski, S., Peters, S.et al. (2000). Genetic background of apparently idiopathic sporadic cerebellar ataxia. Hum. Genet., 107(2), 132–7CrossRef Google Scholar

Schrag, A., Kingsley, D., Phatouros, C.et al. (1998). Clinical usefulness of magnetic resonance imaging in multiple system atrophy. J. Neurol. Neurosurg. Psychiatr., 65(1), 65–71CrossRef Google Scholar PubMed

Schrag, A., Ben-Shlomo, Y. & Quinn, N. P. (1999). Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study. Lancet, 354, 1771–5CrossRef Google Scholar PubMed

Schrag, A., Good, C. D., Miszkiel, K.et al. (2000). Differentiation of atypical parkinsonian syndromes with routine MRI. Neurology, 54(3), 697–702CrossRef Google Scholar PubMed

Schulz, J. B., Klockgether, T., Petersen, D.et al. (1994). Multiple system atrophy: natural history, MRI morphology, and dopamine receptor imaging with 123IBZM-SPECT. J. Neurol. Neurosurg. Psychiatr., 57(9), 1047–56CrossRef Google Scholar PubMed

Schulz, J. B., Skalej, M., Wedekind, D.et al. (1999). Magnetic resonance imaging-based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy. Ann. Neurol., 45, 65–743.0.CO;2-1>CrossRef Google Scholar PubMed

Schwarz, J., Tatsch, K., Arnold, G.et al. (1992). 123I-iodobenzamide-SPECT predicts dopaminergic responsiveness in patients with de novo parkinsonism. Neurology, 42, 556–61CrossRef Google Scholar PubMed

Schwarz, J., Tatsch, K., Arnold, G.et al. (1993). 123I-iodobenzamide-SPECT in 83 patients with de novo parkinsonism. Neurology, 43, 17–20Google Scholar PubMed

Schwarz, J., Weis, S. & Kraft, E. (1996). Signal changes on MRI and increases in reactive microgliosis, astrogliosis, and iron in the putamen of two patients with multiple system atrophy. J. Neurol. Neurosurg. Psychiatr., 60, 98–101CrossRef Google Scholar PubMed

Schwarz, J., Tatsch, K., Gasser, T.et al. (1998). 123I-IBZM binding compared with long-term clinical follow up in patients with de novo parkinsonism. Mov. Disord., 13(1), 16–19CrossRef Google Scholar PubMed

Seppi, K., Puschban, Z., Stefanova, N. et al. (2001). Overstimulation of the alpha1B-adrenergic receptor causes a “seizure plus” syndrome. Nat. Med., 7(2), 132CrossRef Google Scholar PubMed

Seppi, K., Schocke, M. F., Esterhammer, R.et al. (2003). Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophy. Neurology, 60(6), 922–7CrossRef Google Scholar

Shinotoh, H., Aotsuka, A., Inoue, O.et al. (1991). Imaging of dopamine D1 and D2 receptors by a high resolution positron emission tomography. Adv. Exp. Med. Biol., 287, 294–53Google Scholar PubMed

Shinotoh, H., Inoue, O., Hirayama, K.et al. (1993). Dopamine D1 receptors in Parkinson's disease and striatonigral degeneration: a positron emission tomography study. J. Neurol. Neurosurg. Psychiatr., 56(5), 467–72CrossRef Google Scholar PubMed

Shy, G. M. & Drager, G. A. (1960). A neurological syndrome associated with orthostatic hypotension. A clinicopathological study. Arch. Neurol., 2, 511–27CrossRef Google Scholar

Silber, M. H. & Levine, S. (2000). Stridor and death in multiple system atrophy. Mov. Disord., 15(4), 699–7043.0.CO;2-L>CrossRef Google Scholar PubMed

Silveira, I., Lopes-Cendes, I., Kish, S.et al. (1996). Frequency of spinocerebellar ataxia type 1, dentatorubropallidoluysian atrophy, and Machado–Joseph disease mutations in a large group of spinocerebellar ataxia patients. Neurology, 46(1), 214–18CrossRef Google Scholar

Sima, A. A. F., Caplan, M., D'Amato, C. J., Pevzner, M. & Furlong, J. W. (1993). Fulminant multiple system atrophy in a young adult presenting as motor neuron disease. Neurology, 43, 2031–5CrossRef Google Scholar

Spillantini, M. G., Schmidt, M. L., Lee, V. M., Trojanowski, J. Q., Jakes, R. & Goedert, M. (1979). Alpha-synuclein in Lewy bodies. Nature, 388(6645), 839–40CrossRef Google Scholar

Spillantini, M. G., Crowther, R. A., Jakes, R., Cairns, N. J., Lantos, P. L. & Goedert, M. (1998). Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. Neurosci. Lett., 251(3), 205–8CrossRef Google Scholar PubMed

Spokes, E. G., Bannister, R. & Oppenheimer, D. R. (1979). Multiple system atrophy with autonomic failure: clinical, histological and neurochemical observations on four cases. J. Neurol. Sci., 43(1), 59–82CrossRef Google Scholar PubMed

Stauffenberg, (1918). Zur Kenntnis des extrapyramidalen motorischen Systems und Mitteilung eines Falles von sog. “Atrophie olivo-pontocérébelleuse”. Z. Gesamte. Neurol. Psychiatri., 39, 1–55CrossRef Google Scholar

Stefanis, L., Kholodilov, N., Ridcout, H. J., Burke, R. E. & Greene, L. A. (2001). Synuclein-1 is selectively up-regulated in response to nerve growth factor treatment in PC12 cells. J. Neurochem., 76(4), 1165–76CrossRef Google Scholar PubMed

Stell, R. & Bronstein, A. M. (1994). Eye abnormalities in extrapyramidal diseases. In Movement Disorders 3, ed. C. D. Marsden & S. Fahn. London: Butterworth-Heinemann, pp. 88–113

Stern, M. B., Braffman, B. H., Skolnick, B. E., Hurtig, H. I. & Grossman, R. I. (1989). Magnetic resonance imaging in Parkinson's disease and parkinsonian syndromes. Neurology, 39, 1524–6CrossRef Google Scholar PubMed

Stocchi, F., Badiali, D., Vacca, L.et al. (2000). Anorectal function in multiple system atrophy and Parkinson's disease. Mov. Disord., 15(1), 71–63.0.CO;2-W>CrossRef Google Scholar PubMed

Strijks, E., van't Hof, M., Sweep, F., Lenders, J. W., Oyen, W. J. & Horstink, M. W. (2002). Stimulation of growth-hormone release with clonidine does not distinguish individual cases of idiopathic Parkinson's disease from those with striatonigral degeneration. J. Neurol., 249(9), 1206–10CrossRef Google Scholar

Suemaru, S., Suemaru, K., Kawai, K.et al. (1995). Cerebrospinal fluid corticotrophin-releasing hormone in neurodegenerative diseases: reduction in spinocerebellar degeneration. Life Sci., 57(24), 2231–5CrossRef Google Scholar PubMed

Sung, J. H., Mastri, A. R. & Segal, E. (1979). Pathology of Shy–Drager syndrome. J. Neuropathol. Exp. Neurol., 38(4), 353–68CrossRef Google Scholar PubMed

Takahashi, M., Ohta, S., Matsuoka, S., Mori, H. & Mizuno, Y. (2002). Mixed multiple system atrophy and progressive supranuclear palsy: a clinical and pathological report of one case. Acta Neuropathol. (Berl.), 103(1), 82–7CrossRef Google Scholar

Takatsu, H., Nagashima, K., Murase, M., Fujiwara, H., Nishida, H. & Matsuo, H. (2000). Differentiating Parkinson disease from multiple-system atrophy by measuring cardiac iodine-123 metaiodobenzymguanidine accumulation. J. Am. Med. Assoc., 284(1), 44–5CrossRef Google Scholar PubMed

Taki, J., Nakajima, K., Hwang, E. H., Matsunari, I., Komai, K. & Yoshita, M. (2000). Peripheral sympathetic dysfunction in patients with Parkinson's disease without autonomic failure is heart selective and disease specific. Eur. J. Nucl. Med., 27, 566–73CrossRef Google Scholar PubMed

Testa, D., Filippini, G., Farinotti, M., Palazzini, E. & Caraceni, T. (1996). Survival in multiple system atrophy: a study of prognostic factors in 59 cases. J. Neurol., 243, 401–4CrossRef Google Scholar PubMed

Thobois, S., Broussolle, E., Toureille, L. & Vial, C. (2001). Severe dysphagia after botulinum toxin injection for cervical dystonia in multiple system atrophy. Mov. Disord., 16, 764–5CrossRef Google Scholar PubMed

Tison, F., Wenning, G. K., Daniel, S. E. & Quinn, N. (1995a). The pathophysiology of parkinsonism in multiple system atrophy. Eur. J. Neurol., 2, 435–44CrossRef Google Scholar

Tison, F., Wenning, G. K., Quinn, N. P. & Smith, S. J. (1995b). REM sleep behaviour disorder as the presenting symptom of multiple system atrophy. J. Neurol. Neurosurg. Psychiatr., 58(3), 379–80CrossRef Google Scholar

Tison, F., Arne, P., Sourgen, C., Chrysostome, V. & Yeklef, F. (2000a). The value of external anal sphincter electromyography for the diagnosis of multiple system atrophy. Mov. Disord., 15(6), 1148–573.0.CO;2-6>CrossRef Google Scholar

Tison, F., Yekhlef, F., Chrysostome, V. & Sourgen, C. (2000b). Prevalence of multiple system atrophy. Lancet, 355(9202), 495–6CrossRef Google Scholar

Togo, T., Iseki, E., Marui, W., Akiyama, H., Ueda, K. & Kosaka, K. (2001). Glial involvement in the degeneration process of Lewy body-bearing neurons and the degradation process of Lewy bodies in brains of dementia with Lewy bodies. J. Neurol. Sci., 184(1), 71–5CrossRef Google Scholar PubMed

Tranchant, C., Guiraud-Chaumeil, C., Echaniz-Laguna, A. & Warter, J. M. (2000). Is clonidine growth hormone stimulation a good test to differentiate multiple system atrophy from idiopathic Parkinson's disease?J. Neurol., 247(11), 853–6CrossRef Google Scholar PubMed

Trenkwalder, C., Schwarz, J., Gebhard, J.et al. (1995). Starnberg trial on epidemiology of parkinsonism and hypertension in the elderly. Prevalence of Parkinson's disease and related disorders assessed by a door-to-door survey of inhabitants older than 65 years. Arch. Neurol., 52, 1017–22CrossRef Google Scholar

Trojanowski, J. Q. (2002). Tauists, baptists, syners, apostates, and new data. Ann. Neurol., 52(3), 263–5CrossRef Google Scholar PubMed

Tsuchiya, K., Ozawa, E., Haga, C.et al. (2000). Constant involvement of the Betz cells and pyramidal tract in multiple system atrophy: a clinicopathological study of seven autopsy cases. Acta Neuropathol. (Berl.), 99(6), 628–36CrossRef Google Scholar PubMed

Tsuda, T., Onodera, H., Okabe, S., Kikuchi, Y. & Itoyama, Y. (2002). Impaired chemosensitivity to hypoxia is a marker of multiple system atrophy. Ann. Neurol., 52(3), 367–71CrossRef Google Scholar PubMed

Tu, P. H., Galvin, J. E., Baba, M.et al. (1998). Glial cytoplasmatic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein. Ann. Neurol., 44(3), 415–22CrossRef Google Scholar

Urenjak, J., Williams, S. R., Gadian, D. G. & Noble, M. (1993). Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neuronal cell types. J. Neurosci., 13, 981–9CrossRef Google Scholar

Uversky, V. N. & Fink, A. L. (2002). Amino acid determinants of alpha-synuclein aggregation: putting together pieces of the puzzle. FEBS Lett., 522(1–3), 9–13CrossRef Google Scholar PubMed

Uversky, V. N., Li, J., Souillac, P.et al. (2002). Biophysical properties of the synucleins and their propensities to fibrillate: inhibition of alpha-synuclein assembly by beta- and gamma-synucleins. J. Biol. Chem., 277(14), 11970–8CrossRef Google Scholar PubMed

Valldeoriola, F., Valls-Sole, J., Tolosa, E. S. & Marti, M. J. (1995). Striated anal sphincter denervation in patients with progressive supranuclear palsy. Mov. Disord., 10(5), 550–5CrossRef Google Scholar PubMed

Vanacore, N., Bonifati, V., Fabbrini, G.et al. (2000). Smoking habits in multiple system atrophy and progressive supranuclear palsy. Neurology, 54, 114–19CrossRef Google Scholar PubMed

Vanacore, N., Bonifati, V., Fabbrini, G. et al. (ESGAP) (2004). Case-control study of multiple system atrophy. Mov. Disord. (in press)

Eecken, H., Adams, R. D. & Bogaert, L. (1960). Striopallidal-nigral degeneration. A hitherto undescribed lesion in paralysis agitans. J. Neuropathol. Exp. Neurol., 19, 159–61Google Scholar

Royen, E., Verhoeff, N. F., Speelman, J. D., Wolters, E. C., Kuiper, M. A. & Janssen, A. G. (1993). Multiple system atrophy and progressive supranuclear palsy. Diminished striatal D2 dopamine receptor activity demonstrated by 123I-IBZM single photon emission computed tomography. Arch. Neurol., 50(5), 513–16CrossRef Google Scholar PubMed

Varrone, A., Marek, K. L., Jennings, D., Innis, R. B. & Seibyl, J. P. (2001). (123)I-beta-CIT SPECT imaging demonstrates reduced density of striatal dopamine transporters in Parkinson's disease and multiple system atrophy. Mov. Disord., 16, 1023–32CrossRef Google Scholar PubMed

Vartanian, T., Corfas, G., Li, Y., Fischbach, G. D. & Stefansson, K. (1994). A role for the acetylcholine receptor-inducing protein ARIA in oligodendrocyte development. Proc. Natl Acad. Sci., USA, 91(24), 11626–30CrossRef Google Scholar PubMed

Vartanian, T., Goodearl, A., Vichover, A. & Fischbach, G. (1997). Axonal neuregulin signals cells of the oligodendrocyte lineage through activation of HER4 and Schwann cells through HER2 and HER3. J. Cell. Biol., 137(1), 211–20CrossRef Google Scholar PubMed

Vidailhet, M., Rivaud, S., Gouider-Khouja, N.et al. (1994). Eye movements in parkinsonian syndromes. Ann. Neurol., 35, 420–6CrossRef Google Scholar PubMed

Vila, M., Jackson-Lewis, V., Guegan, C.et al. (2001). The role of glial cells in Parkinson's disease. Curr. Opin. Neurol., 14(4), 483–9CrossRef Google Scholar PubMed

Visser-Vandewalle, V., Temel, Y., Colle, H. & Linden, C. (2003). Bilateral high-frequency stimulation of the subthalamic nucleus in patients with multiple system atrophy – parkinsonism. Report of four cases. J. Neurosurg., 98(4), 882–7CrossRef Google Scholar PubMed

Vodusek, B. (2001). Sphincter EMG and differential diagnosis of multiple system atrophy. Mov. Disord., 16(4), 600–7CrossRef Google Scholar PubMed

Vogels, O. J., Veltman, J., Oyen, W. J. & Horstink, M. W. (2000). Decreased striatal dopamine D2 receptor binding in amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA): D2 receptor down-regulation versus striatal cell degeneration. J. Neurol. Sci., 180(1–2), 62–5CrossRef Google Scholar PubMed

Wakabayashi, K., Hayashi, S., Kakita, A.et al. (1998a). Accumulation of alpha-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy. Acta Neuropathol. (Berl.), 96(5), 445–52CrossRef Google Scholar

Wakabayashi, K., Ikeuchi, T., Ishikawa, A. & Takahashi, H. (1998b). Multiple system atrophy with severe involvement of the motor cortical areas and cerebral white matter. J. Neurol. Sci., 156(1), 114–17CrossRef Google Scholar

Wakabayashi, K., Yoshimoto, M., Tsuji, S. & Takahashi, H. (1998c). Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. Neurosci. Lett., 249(2–3), 180–2CrossRef Google Scholar

Wakabayashi, K., Engelender, S., Yoshimoto, M., Tsuji, S., Ross, C. A. & Takahashi, H. (2000). Synphilin-1 is present in Lewy bodies in Parkinson's disease. Ann. Neurol., 47(4), 521–33.0.CO;2-B>CrossRef Google Scholar PubMed

Wakabayashi, K., Engelender, S., Tanaka, Y.et al. (2002). Immunocytochemical localization of synphilin-1, an alpha-synuclein-associated protein, in neurodegenerative disorders. Acta Neuropathol. (Berl.), 103(3), 209–14CrossRef Google Scholar PubMed

Wakai, M., Kume, A., Takahashi, A., Ando, T. & Hashizume, Y. (1994). A study of parkinsonism in multiple system atrophy: clinical and MRI correlation. Acta Neurol. Scand., 90, 225–31CrossRef Google Scholar PubMed

Waldner, R., Puschban, Z., Scherfler, C., Seppi, K., Jellinger, K. & Poewe, W. (2001). No functional effects of embryonic neuronal grafts on motor deficits in a 3-nitropropionic acid rat model of advanced striatonigral degeneration (multiple system atrophy). Neuroscience, 102(3), 581–92CrossRef Google Scholar

Watanabe, H., Saito, Y., Terao, S.et al. (2002). Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients. Brain, 125, 1070–83CrossRef Google Scholar PubMed

Wenning, G. K., Wagner, S., Daniel, S. E. & Quinn, N. P. (1993). Multiple system atrophy: sporadic or familial?Lancet, 342(8872), 681CrossRef Google Scholar PubMed

Wenning, G. K., Ben Shlomo, Y., Magalhaes, M., Daniel, S. E. & Quinn, N. P. (1994a). Clinical features and natural history of multiple system atrophy. An analysis of 100 cases. Brain, 117(4), 835–45CrossRef Google Scholar

Wenning, G. K., Quinn, N., Magalhaes, M., Mathias, C. & Daniel, S. E. (1994b). “Minimal change” multiple system atrophy. Mov. Disord., 9(2), 161–6CrossRef Google Scholar

Wenning, G. K. & Geser, F. (2003). Atrophie multisystematisee. Rev. Neurol. (Paris., 159(5 Pt 2), 31–8Google Scholar

Wenning, G. & Quinn, N. (1994). Are Lewy bodies non-specific epiphenomena of nigral damage?Mov. Disord., 9(3), 378–9CrossRef Google Scholar PubMed

Wenning, G. K. & Quinn, N. P. (1997a). Multiple system atrophy. In Bailliere's Clin. Neurol., ed. N. P. Quinn, 6, 187–204

Wenning, G. K. & Smith, S. J. M. (1997b). Magnetic brain stimulation in multiple system atrophy. Mov. Disord., 12(3), 452–3CrossRef Google Scholar

Wenning, G. K., Ben-Shlomo, Y., Magalhaes, M., Daniel, S. E. & Quinn, N. P. (1995). Clinicopathological study of 35 cases of multiple system atrophy. J. Neurol. Neurosurg. Psychiatr., 58, 160–6CrossRef Google Scholar PubMed

Wenning, G. K., Granata, R., Laboyrie, P. M., Quinn, N. P., Jenner, P. & Marsden, C. D. (1996a). Reversal of behavioural abnormalities by fetal allografts in a novel rat model of striatonigral degeneration. Mov. Disord., 11(5), 522–32CrossRef Google Scholar

Wenning, G. K., Quinn, N. P., Daniel, S. E., Garratt, H. & Marsden, C. D. (1996b). Facial dystonia in pathologically proven multiple system atrophy: a video report. Mov. Disord., 11(1), 107–9CrossRef Google Scholar

Wenning, G. K., Tison, F., Elliott, L., Quinn, N. P. & Daniel, S. E. (1996c). Olivopontocerebellar pathology in multiple system atrophy. Mov. Disord., 11(2), 157–62CrossRef Google Scholar

Wenning, G. K., Kraft, E., Beck, R.et al. (1997a). Cerebellar presentation of multiple system atrophy. Mov. Disord., 12(1), 115–17CrossRef Google Scholar

Wenning, G. K., Tison, F., Ben Shlomo, Y., Daniel, S. E. & Quinn, N. P. (1997b). Multiple system atrophy: a review of 203 pathologically proven cases. Mov. Disord., 12(2), 133–47CrossRef Google Scholar

Wenning, G. K., Ebersbach, G., Verny, M.et al. (1999a). Progression of falls in postmortem-confirmed parkinsonian disorders. Mov. Disord., 14, 947–503.0.CO;2-O>CrossRef Google Scholar

Wenning, G. K., Granata, R., Puschban, Z., Scherfler, C. & Poewe, W. (1999b). Neural transplantation in animal models of multiple system atrophy: a review. J. Neural Transm., 55, 103–13Google Scholar

Wenning, G. K., Scherfler, C., Granata, R., Bösch, S., Verny, M. & Chaudhuri, K. R. (1999c). Time course of symptomatic orthostatic hypotension and urinary incontinence in patients with postmortem confirmed parkinsonian syndromes: a clinicopathological study. J. Neurol. Neurosurg. Psychiatr., 67, 620–3CrossRef Google Scholar

Wenning, G. K., Ben-Shlomo, Y., Hughes, A., Daniel, S. E., Lees, A. J. & Quinn, N. P. (2000a). What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson's disease?J. Neurol. Neurosurg. Psychiatr., 68(4), 434–40CrossRef Google Scholar

Wenning, G. K., Jellinger, K. J., Quinn, N. P. & Poewe, W. H. (2000b). An early report of striatonigral degeneration. Mov. Disord., 15(1), 159–623.0.CO;2-I>CrossRef Google Scholar

Wenning, G. K., Tison, F., Scherfler, C.et al. (2000c). Towards neurotransplantation in multiple system atrophy: clinical rationale, pathophysiological basis, and preliminary experimental evidence. Cell Transpl., 9, 279–88CrossRef Google Scholar

Wenning, G. K., Seppi, K., Sampaio, C., Quinn, N. P., Poewe, W. & Tison, F. (2002). European Multiple System Atrophy Study Group (EMSA-SG): Validation of the Unified MSA Rating Scale (UMSARS). Mov. Disord., 17(Suppl 5), 252Google Scholar

Wenning, G. K., Geser, F. & Poewe, W. (2003a). The ‘risus sardonicus’ of multiple system atrophy. Mov. Disord., 18(10), 1211CrossRef Google Scholar

Wenning, G. K., Geser, F., Stampfer-Kountchev, M. & Tison, F. (2003b). Multiple system atrophy: an update. Mov. Disord., 18 (suppl. 6), S34–42CrossRef Google Scholar

Wermuth, L., Joensen, P., Bunger, N. & Jeune, B. (1997). High prevalence of Parkinson's disease in the Faroe Islands. Neurology, 49, 426–32CrossRef Google Scholar PubMed

Wiedemann, P., Bonisch, H., Oerters, F. & Bruss, M. (2002). Structure of the human histamine H3 receptor gene (HRH3) and identification of naturally occurring variations. J. Neural Transm., 109(4), 443–53CrossRef Google Scholar PubMed

Williams, A., Hanson, D. & Calne, D. B. (1979). Vocal cord paralysis in the Shy–Drager syndrome. J. Neurol. Neurosurg. Psychiatr., 42, 151–3CrossRef Google Scholar PubMed

Winkler, A. S., Marsden, J., Parton, M., Watkins, P. J. & Chaudhuri, K. R. (2001). Erythropoietin deficiency and anaemia in multiple system atrophy. Mov. Disord., 16, 233–9CrossRef Google Scholar PubMed

Wright, R. A., Kaufmann, H. C., Perera, R.et al. (1998). A double-blind, dose response study of midodrine in neurogenic orthostatic hypotension. Neurology, 51(1), 120–4CrossRef Google Scholar PubMed

Wüllner, U., Klockgether, T., Petersen, D., Naegele, T. & Dichgans, J. (1993). Magnetic resonance imaging in hereditary and idiopathic ataxia. Neurology, 43, 318–25CrossRef Google Scholar PubMed

Yamada, T. & McGeer, P. L. (1990). Oligodendroglial microtubular masses: an abnormality observed in some human neurodegenerative diseases. Neurosci. Lett., 120(2), 163–6CrossRef Google Scholar PubMed

Yang, X., Kuo, Y., Devay, P., Yu, C. & Role, L. (1998). A cysteine-rich isoform of neuregulin controls the level of expression of neuronal nicotinic receptor channels during synaptogenesis. Neuron, 20(2), 255–70CrossRef Google Scholar PubMed

Yekhlef, F., Ballan, G., Macia, F., Delmer, O., Sourgen, C. & Tison, F. (2003). Routine MRI for the differential diagnosis of Parkinson's disease, MSA, PSP, and CBD. J. Neural Transm., 110(2), 151–69CrossRef Google Scholar PubMed

Yoshita, M. (1998). Differentiation of idiopathic Parkinson's disease from striatonigral degeneration and progressive supranuclear palsy using iodine-123 meta-iodobenzylguanidine myocardial scintigraphy. J. Neurol. Sci., 155, 60–7CrossRef Google Scholar PubMed

Yuan, J. & Yankner, B. A. (2000). Apoptosis in the nervous system. Nature, 407(6805), 802–9CrossRef Google Scholar

Zesiewicz, T. A., Helal, M. & Hauser, R. A. (2002). Sildenafil citrate (Viagra) for the treatment of erectile dysfunction in men with Parkinson's disease. Mov. Disord., 15, 305–83.0.CO;2-W>CrossRef Google Scholar

Ziegler, M. G., Lake, C. R. & Kopin, I. J. (1977). The sympathetic-nervous-system defect in primary orthostatic hypotension. N. Engl. J. Med., 296(6), 293–7CrossRef Google Scholar PubMed

Zoukos, Y., Thomaides, T., Pavitt, D. V., Cuzner, M. L. & Mathias, C. J. (1993). Beta-adrenoceptor expression on circulating mononuclear cells of idiopathic Parkinson's disease and autonomic failure patients before and after reduction of central sympathetic outflow by clonidine. Neurology, 43(6), 1181–7CrossRef Google Scholar PubMed

Zuscik, M. J., Sands, S., Ross, S. A.et al. (2000). Overexpression of the alpha1B-adrenergic receptor causes apoptotic neurodegeneration: multiple system atrophy. Nat. Med., 6(12), 1388–94CrossRef Google Scholar PubMed

Zuscik, M. J., Chalothorn, D., Hellard, D.et al. (2001). Hypotension, autonomic failure, and cardiac hypertrophy in transgenic mice overexpressing the alpha 1B-adrenergic receptor. J. Biol. Chem., 276(17), 13738–43CrossRef Google Scholar PubMed